On April 6, University of California San Diego and BioMed Realty announced the future opening of the Center for Novel Therapeutics, which will be located in the university’s Science and Research Park. While construction will begin during mid-to-late-May, according to Kevin Tremblay, senior director of San Diego BioMed Realty, completion for the new facility is slated for early 2019.
“Although our preliminary discussions date back to 2013, there was a good 12-to 18- month period before the university and ourselves were ready to kick off construction,” said Tremblay. BioMed Realty has a long history of working with top research institutions, including the J. Craig Venter Institute (in San Diego and Maryland), the Broad Institute, the Dana Farber Cancer Institute, and Stanford Health Care.
The Center for Novel Therapeutics will feature an 110,000-square-foot “research hub,” which aims to “leverage the strength of the university’s world-renowned doctors and researchers at the Moores Cancer Center with private sector companies,” according to a recent press release.
The current design for the Center for Novel Therapeutics will create an environment of collaboration throughout the building, with a full range of amenities for tenants and their employees to enjoy, including a conference center, auditorium, modern fitness center and café. The project will also pursue LEED Gold certification. Some of the environmentally-conscious practices incorporated into the center’s design will include a high-efficiency water-cooled central cooling and heating plant, LED light fixtures, and renewable energy from photovoltaic (solar) panels in a glass room of the atrium. This new research hub should leverage the strength of the university’s world-renowned doctors and research at Moores Cancer Center, with private sector companies looking to translate research into helping patients throughout the world.
The center’s design aims to promote “collaboration throughout the building,” replete with “a full range of amenities for tenants and their employees to enjoy, including a conference center, auditorium, modern fitness center and café,” the press release read. Although less than two years away from completion, upon its completion, the Center for Novel Therapeutics will become a major asset to UC San Diego.
“We are proud that the university recognized our unique ability to develop a building that will become a beacon for oncology research around the globe,” said Tremblay. “We look forward to providing more than bricks and mortar, but a facilitator of collaboration that helps scientists work together to positively impact patients with cancer.”